Status:
COMPLETED
STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)
Lead Sponsor:
University of Western Ontario, Canada
Collaborating Sponsors:
Pfizer
Conditions:
Hypertension
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is to assess if the implementation of a treatment algorithm including initial treatment with a low dose diuretic/ACE-inhibitor or ARB combination and subsequently a low dos...
Detailed Description
Utilization of fixed dose combination therapy has been advocated as an adherence-enhancing strategy and has been so recommended in the 2007 Canadian Hypertension Education Program (CHEP) recommendatio...
Eligibility Criteria
Inclusion
- male or female subjects 18 years or older
- documented diagnoses of hypertension and of hypercholesterolemia or current therapy for these conditions
- uncontrolled hypertension (SBP \>140 mmHg or DBP \>90 mmHg) or cholesterol levels above their threshold based on their global atherosclerotic risk profile (based on ATP III assessment)
- ability to give written informed consent
Exclusion
- ischemic heart disease, atrial fibrillation, chronic kidney disease and significant liver disease
- currently prescribed 3 or more drugs to control blood pressure
- currently prescribed 2 or more drugs to control hypercholesterolemia
- participating in other hypertension/hypercholesterolemia studies
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00637078
Start Date
February 1 2008
End Date
December 1 2010
Last Update
June 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robarts Research Insititute
London, Ontario, Canada, N6A 5K8